Phase
Condition
Stroke
Cerebral Ischemia
Treatment
Control targeted auditory stimulation during sleep (TASS sham intervention)
Targeted auditory stimulation during sleep (TASS verum intervention)
Hyper-personalized feedback (HPF intervention)
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Ischemic stroke or intracerebral hemorrhage with a gait deficit older than 30 daysbut not more than 6 months.
Functional Ambulation Category ≥3
≥18 years of age
Informed consent as documented by signature
Exclusion
Exclusion Criteria:
Cognitive impairment, Montreal Cognitive Assessment (MoCa) < 20
Comprehensive aphasia precluding the understanding of study-related information
Previous stroke that caused sustained clinically relevant cognitive, visual and/orgait deficits
Expected acute hospitalization during the training period
History of a physical or neurological condition that interferes with studyprocedures
Social and/or personal circumstances that interfere with the ability to return fortherapy sessions and follow-up assessments
Not capable of voluntary gait adaptation
Allergy to nickel
Patients taking benzodiazepines or Z-drugs with a significant effect on sleep EEG
Study Design
Connect with a study center
University Hospital Zurich
Zürich, Zurich 8091
SwitzerlandActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.